{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:25:41Z","timestamp":1791851141358,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ejim.2013.07.004","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T11:31:31Z","timestamp":1375356691000},"page":"597-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD)"],"prefix":"10.1016","volume":"24","author":[{"given":"David N.","family":"O'Dwyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Veale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamas C.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.07.004_bb0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1513\/pats.200703-045MS","article-title":"Rheumatoid lung disease","volume":"4","author":"Brown","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.ejim.2013.07.004_bb0010","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s10198-007-0088-8","article-title":"The burden of rheumatoid arthritis and access to treatment: health burden and costs","volume":"8","author":"Lundkvist","year":"2008","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.ejim.2013.07.004_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-857X(21)00886-3","article-title":"Rheumatoid arthritis","volume":"16","author":"Spector","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ejim.2013.07.004_bb0020","first-page":"3","article-title":"Outcome after 40years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality","volume":"69","author":"Minaur","year":"2004","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.ejim.2013.07.004_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","article-title":"Survival in rheumatoid arthritis: a population-based analysis of trends over 40years","volume":"48","author":"Gabriel","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0030","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0035","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1164\/ajrccm.154.5.8912776","article-title":"Bronchiolar disease in rheumatoid arthritis","volume":"154","author":"Hayakawa","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0040","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1183\/09031936.98.12020444","article-title":"Diffuse panbronchiolitis in rheumatoid arthritis","volume":"12","author":"Homma","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2013.07.004_bb0045","first-page":"471","article-title":"Pulmonary involvement in the collagen vascular diseases","volume":"119","author":"Hunninghake","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejim.2010.02.004","article-title":"Rheumatoid pneumoconiosis (Caplan's syndrome)","volume":"21","author":"Schreiber","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00005792-199405000-00005","article-title":"Bronchiectasis. A late feature of severe rheumatoid arthritis","volume":"73","author":"Shadick","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2013.07.004_bb0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ccm.2010.04.003","article-title":"Pulmonary manifestations of rheumatoid arthritis","volume":"31","author":"Antin-Ozerkis","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0065","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2013.07.004_bb0070","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/qjmed\/hcs076","article-title":"Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?","volume":"105","author":"Mahendran","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.ejim.2013.07.004_bb0075","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0080","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.07.004_bb0085","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2013.07.004_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0100","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/qjmed\/hcs067","article-title":"Review series\u2014inflammation & fibrosis introduction","volume":"105","author":"Donnelly","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.ejim.2013.07.004_bb0110","doi-asserted-by":"crossref","first-page":"872120","DOI":"10.1155\/2011\/872120","article-title":"Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma","volume":"2011","author":"Hamblin","year":"2011","journal-title":"Pulm Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0115","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2009.120626","article-title":"Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0007-0971(65)80050-X","article-title":"Rheumatoid interstitial lung disease","volume":"59","author":"Stack","year":"1965","journal-title":"Br J Dis Chest"},{"key":"10.1016\/j.ejim.2013.07.004_bb0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/ard.28.3.252","article-title":"Diffuse interstitial pulmonary fibrosis and rheumatoid arthritis","volume":"28","author":"Walker","year":"1969","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0130","first-page":"33","article-title":"Cause of death in 81 autopsied patients with rheumatoid arthritis","volume":"21","author":"Suzuki","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.63.1.27","article-title":"Pulmonary dysfunction in rheumatoid disease","volume":"63","author":"Frank","year":"1973","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.07.004_bb0140","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.resp.2009.01.010","article-title":"Mechanisms of activity-related dyspnea in pulmonary diseases","volume":"167","author":"O'Donnell","year":"2009","journal-title":"Respir Physiol Neurobiol"},{"issue":"7","key":"10.1016\/j.ejim.2013.07.004_bb0155","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00296-012-2659-y","article-title":"Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis","volume":"33","author":"Shahane","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ejim.2013.07.004_bb0160","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijcard.2007.04.084","article-title":"Pulmonary hypertension in rheumatoid arthritis\u2014relation with the duration of the disease","volume":"127","author":"Udayakumar","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0165","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.07.004_bb0170","first-page":"770","article-title":"Lung biopsy in rheumatoid arthritis","volume":"131","author":"Yousem","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0175","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.rmed.2012.04.004","article-title":"Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases","volume":"106","author":"Nakamura","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0180","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1183\/09031936.02.00492002","article-title":"ATS\/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias","volume":"19","author":"Demedts","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2013.07.004_bb0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thorax.58.2.143","article-title":"Radiological versus histological diagnosis in UIP and NSIP: survival implications","volume":"58","author":"Flaherty","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.ejim.2013.07.004_bb0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1164\/ajrccm.164.2.2101090","article-title":"Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis","volume":"164","author":"Hunninghake","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00296-004-0527-0","article-title":"Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis","volume":"26","author":"Yoshinouchi","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ejim.2013.07.004_bb0200","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.200611-1685OC","article-title":"Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project","volume":"177","author":"Travis","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0205","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1378\/chest.08-2572","article-title":"Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia","volume":"136","author":"Song","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.07.004_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.20765","article-title":"Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis","volume":"52","author":"Turesson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0220","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0225","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.1780391014","article-title":"Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities","volume":"39","author":"Saag","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/03009749509099296","article-title":"Relationship of rheumatoid factor to lung diffusion capacity in smoking and non-smoking patients with rheumatoid arthritis","volume":"24","author":"Luukkainen","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10067-005-1158-x","article-title":"Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms","volume":"25","author":"Ayhan-Ardic","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.56.8.463","article-title":"Cigarette smoking and rheumatoid arthritis severity","volume":"56","author":"Saag","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.054445","article-title":"Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0250","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"Ronnelid","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","article-title":"Citrullination in extra-articular manifestations of rheumatoid arthritis","volume":"46","author":"Bongartz","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2013.07.004_bb0265","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/ard.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","volume":"67","author":"Makrygiannakis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0270","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10067-007-0800-1","article-title":"Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis","volume":"27","author":"Alexiou","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0275","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/art.37881","article-title":"Identification of citrullinated heat shock protein 90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease","volume":"65","author":"Harlow","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0280","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0285","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3899\/jrheum.101261","article-title":"High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis","volume":"38","author":"Aubart","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0290","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10067-009-1128-9","article-title":"Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA","volume":"28","author":"Gizinski","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0295","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/art.1780290502","article-title":"Alpha 1-antitrypsin phenotypes, including M subtypes, in pulmonary disease associated with rheumatoid arthritis and systemic sclerosis","volume":"29","author":"Michalski","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0300","first-page":"97","article-title":"HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis","volume":"9","author":"Charles","year":"1991","journal-title":"Dis Markers"},{"key":"10.1016\/j.ejim.2013.07.004_bb0305","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2169\/internalmedicine.33.612","article-title":"Diffuse panbronchiolitis and rheumatoid arthritis: a possible correlation with HLA-B54","volume":"33","author":"Sugiyama","year":"1994","journal-title":"Intern Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0310","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(73)90040-5","article-title":"The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases","volume":"54","author":"Gordon","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0315","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/qjmed\/hcs066","article-title":"Clinical trials and tribulations\u2014lessons from pulmonary fibrosis","volume":"105","author":"Olson","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.ejim.2013.07.004_bb0320","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.200204-373OC","article-title":"Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease","volume":"167","author":"Flaherty","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0325","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/thx.47.12.1035","article-title":"Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up","volume":"47","author":"Agusti","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.ejim.2013.07.004_bb0330","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1164\/ajrccm.149.6.8004317","article-title":"Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis","volume":"149","author":"Wells","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0335","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","article-title":"Polymyositis\u2013dermatomyositis-associated interstitial lung disease","volume":"164","author":"Douglas","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0340","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","article-title":"Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis","volume":"61","author":"Dawson","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0345","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00008483-200607000-00007","article-title":"Effectiveness of pulmonary rehabilitation in restrictive lung disease","volume":"26","author":"Naji","year":"2006","journal-title":"J Cardiopulm Rehabil"},{"key":"10.1016\/j.ejim.2013.07.004_bb0350","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/thx.2007.088070","article-title":"Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease","volume":"63","author":"Holland","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.ejim.2013.07.004_bb0355","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.30077","article-title":"Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease","volume":"63","author":"Cottin","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0360","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-62-4-685","article-title":"Rheumatoid lung disease","volume":"62","author":"Patterson","year":"1965","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0365","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","article-title":"Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"171","author":"Azuma","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0370","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0375","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3346\/jkms.2002.17.2.270","article-title":"Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report","volume":"17","author":"Chang","year":"2002","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ejim.2013.07.004_bb0380","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/1529-0131(199807)41:7<1215::AID-ART11>3.0.CO;2-Y","article-title":"Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases","volume":"41","author":"Schnabel","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0385","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1517\/14656560802591430","article-title":"Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease","volume":"9","author":"Kelly","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejim.2013.07.004_bb0390","first-page":"243","article-title":"Drug-induced pneumonitis: the role of methotrexate","volume":"18","author":"Zisman","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0395","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2169\/internalmedicine.43.1201","article-title":"Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction","volume":"43","author":"Kamata","year":"2004","journal-title":"Intern Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0400","first-page":"1927","article-title":"Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gaffo","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0405","first-page":"1151","article-title":"Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis","volume":"34","author":"Hagiwara","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0410","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/bmj.329.7477.1266","article-title":"Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab","volume":"329","author":"Ostor","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2013.07.004_bb0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.21716","article-title":"Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab","volume":"55","author":"Schoe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0420","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.07.004_bb0425","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.122.3.1093","article-title":"Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition","volume":"122","author":"Vassallo","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.07.004_bb0430","first-page":"23","article-title":"Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease","volume":"25","author":"Antoniou","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0435","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MCP.0b013e3283483ea5","article-title":"Biological treatments and connective tissue disease associated interstitial lung disease","volume":"17","author":"Panopoulos","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0440","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0030-1249110","article-title":"Interstitial lung disease and lung transplantation","volume":"31","author":"O'Beirne","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0445","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1399-0012.2009.00958.x","article-title":"Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation","volume":"23","author":"Shitrit","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ejim.2013.07.004_bb0450","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archinte.168.15.1718","article-title":"Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug","volume":"168","author":"Saketkoo","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2013.07.004_bb0455","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0460","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0012-3692(15)50949-5","article-title":"Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease","volume":"130","author":"Swigris","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.07.004_bb0465","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/annrheumdis-2011-200170","article-title":"Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE","volume":"71","author":"Tak","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0470","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2012-eular.2085","article-title":"Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients","author":"van Vollenhoven","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.07.004_bb0475","first-page":"S17","article-title":"Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis","volume":"30","author":"Daoussis","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2013.07.004_bb0480","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00296-012-2587-x","article-title":"Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience","volume":"33","author":"Braun-Moscovici","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ejim.2013.07.004_bb0485","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/rheumatology\/ker290","article-title":"Non-infectious pulmonary toxicity of rituximab: a systematic review","volume":"51","author":"Hadjinicolaou","year":"2012","journal-title":"Rheumatology (Oxford)"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:26:58Z","timestamp":1760606818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513001829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0953620513001829"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.07.004","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}